Results driven professional with strong leadership skills and business acumen gained from experience in business development, finance, market research, strategic planning, and sales. In depth knowledge of drug discovery and development built on experience as a biochemist at Merck working on an oncology program that started in discovery and progressed into clinical trials. Selected Business Development Transactions: - Alder Rheumatoid Arthritis License ALD518 (Phase 2) - Ensemble Research Collaboration - Exelixis Oncology Collaboration - Adnexus Therapeutics Acquisition - Pfizer Apixaban Co-Development / Co-Commercialization - Adnexus Oncology Research Collaboration ('08 Allicense “Deal of the Year”)

Exec Director - North America Business Development @ North America Business & Corporate Development From March 2011 to Present (4 years 8 months) Greater Philadelphia AreaDirector, Business Development @ Lead negotiator for the Adnexus Oncology Partnership which won 2008 Allicense “Deal of the Year” From October 2005 to March 2011 (5 years 6 months) Associate Director Finance, Business Development @ Support Corporate and Business Development in assessing the commercial attractiveness and economic feasibility of opportunities. From May 2005 to November 2005 (7 months) Finance Manager, External Development & Strat Plan @ Identify key economic drivers of projects to develop discounted cash flow models for valuation of external technologies, strategic initiatives, and businesses. Finance lead for strategic plan and annual budget. From April 2000 to April 2005 (5 years 1 month) Diabetes Pharmaceutical Sales @ Successfully launched Actos, promoted an insulin delivery device and Prozac. Recognized as a top performer with a monthly ranking as high as 3 out of 510 representatives in the country and was consistently in the top 10%. From April 1998 to April 2000 (2 years 1 month) Biochemist - Oncology Drug Discovery @ Responsible for primary high throughput screening, enzyme purification and enzyme kinetics of Farnesyl Protein Transferase. Instrumental in establishing a pharmacokinetic / pharmacodynamic assay by LC/MS. From 1995 to 1998 (3 years)

MBA, Finance @ Drexel University From 1999 to 2003 BS, Biochemistry @ University of Pittsburgh From 1990 to 1994 Ian Greenberg is skilled in: Drug Discovery, Oncology, Clinical Trials, Assay Development, Business Development, Mergers & Acquisitions, Diabetes, Market Research, Pharmaceutical Sales, Leadership, Strategic Planning, Pharmacokinetics, Protein Chemistry, Finance, Valuation, Budgets, High Throughput..., Negotiation, Pharmaceutical Industry, Sales, Clinical Development